MedPath

REVEAL Study: Vessel Healing After Angioplasty

Completed
Conditions
Coronary Artery Disease
Registration Number
NCT00799344
Lead Sponsor
CeloNova BioSciences, Inc.
Brief Summary

To address early vessel healing and thrombus formation after deployment of three distinct groups of stents

Detailed Description

A prospective, randomized study providing new evidences on early vessel healing and thrombus development after stenting with different devices.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Lesion length ≤ 20 mm
  • Two significant short lesions
Exclusion Criteria
  • Life expectancy < 1 year
  • Left ventricular ejection fraction (LVEF) <30%
  • Chronic kidney disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
percentage of "healed stent struts" at 28-32 days30 days
Secondary Outcome Measures
NameTimeMethod
Measurement of neointimal growth on stent struts30 days

Trial Locations

Locations (1)

Ferrarotto Hospital

🇮🇹

Catania, Sicily, Italy

Ferrarotto Hospital
🇮🇹Catania, Sicily, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.